FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eduard Stange

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Physiology

Innate Immunity

Co-author Network

Publications

TOP 3
Sieglinde Angelberger; Simon Bar-Meir; Karin Dilger; Roland Greinwald; Klaus R Herrlinger; Milan Lukas; Ralph Mueller; Wolfgang Petritsch; Elke Schaeffeler; Matthias Schwab; Olga Shonova; Eduard F Stange; Alexander Teml; Walter Reinisch
Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Svetlana Becker; Tobias A Oelschlaeger; Manolis Pasparakis; Eduard F Stange; Jan Wehkamp; Andy Wullaert; Michael Gersemann
Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo.
Olga Renner; Dominique Richter; Silke Schimmel; Eduard F Stange; André Strohmeyer; Dieter Lütjohann; Oliver Müller; Simone Harsch
Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eduard Stange (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sieglinde Angelberger; Simon Bar-Meir; Karin Dilger; Roland Greinwald; Klaus R Herrlinger; Milan Lukas; Ralph Mueller; Wolfgang Petritsch; Elke Schaeffeler; Matthias Schwab; Olga Shonova; Eduard F Stange; Alexander Teml; Walter Reinisch
Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Inflammatory bowel diseases 2013;19(3):590-8.
2013: Svetlana Becker; Tobias A Oelschlaeger; Manolis Pasparakis; Eduard F Stange; Jan Wehkamp; Andy Wullaert; Michael Gersemann
Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo.
PloS one 2013;8(2):e55620.
2013: Olga Renner; Dominique Richter; Silke Schimmel; Eduard F Stange; André Strohmeyer; Dieter Lütjohann; Oliver Müller; Simone Harsch
Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.
BMC gastroenterology 2013;13():30.
2013: Simon Jäger; Eduard F Stange; Jan Wehkamp
Inflammatory bowel disease: an impaired barrier disease.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2013;398(1):1-12.
2013: K J Schmidt; Eduard F Stange; D Barthel; J Emmrich; Klaus Fellermann; Klaus R Herrlinger; H Koc; H Lehnert; Jürgen Büning
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
Alimentary pharmacology & therapeutics 2013;37(1):129-36.
2012: Anja Troge; Jan Wehkamp; Klaus Heuner; Stefan A Rund; Wolfgang Scheppach; Bjoern O Schroeder; Eduard F Stange; Tobias A Oelschlaeger
More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.
International journal of medical microbiology : IJMM 2012;302(7-8):304-14.
2012: Dominique Richter; Elke Schäffeler; Silke Schimmel; Matthias Schwab; Simone Harsch; Satoko Hirobe-Jahn; Wolfgang Kratzer; Oliver Müller; Olga Renner; André Strohmeyer; Eduard F Stange
MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha.
Journal of proteomics 2012;75(12):3386-99.
2012: Michael Gersemann; Sabine Nuding; German Ott; Naohide Oue; Lena Antoni; Svetlana Becker; Peter Fritz; Jan Wehkamp; Wataru Yasui; Eduard F Stange
Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.
Journal of Crohn's & colitis 2012;6(4):425-34.
2012: M Gersemann; Jan Wehkamp; Eduard F Stange
Innate immune dysfunction in inflammatory bowel disease.
Journal of internal medicine 2012;271(5):421-8.
2012: Zora Teltschik; Reiner Wiest; Julia Beisner; Charles L Bevins; Claudia Hofmann; Sabine Nuding; Juergen Schoelmerich; Eduard F Stange; Jan Wehkamp
Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense.
Hepatology (Baltimore, Md.) 2012;55(4):1154-63.
2012: Eduard F Stange
Extended abstract: Tacrolimus and cyclosporine in inflammatory bowel disease.
Digestive diseases (Basel, Switzerland) 2012;30 Suppl 3():119-20.
2012: Maureen J Koslowski; Irmgard Kübler; Walter Reinisch; Paul Rutgeerts; Elke Schaeffeler; Matthias Schwab; Eduard F Stange; Zora Teltschik; Séverine Vermeire; Guoxing Wang; Julia Beisner; Rachel Cooney; Michael Gersemann; Derek Jewell; Jan Wehkamp
Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
PLoS genetics 2012;8(2):e1002523.
2011: Bjoern O Schroeder; Eduard F Stange; Jan Wehkamp
Waking the wimp: redox-modulation activates human beta-defensin 1.
Gut microbes 2011;2(4):262-6.
2011: Walter Reinisch; Eduard F Stange
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Gut 2011;60(5):739-40.
2011: Klaus R Herrlinger; H Koc; S Winter; A Teml; Eduard F Stange; Klaus Fellermann; P Fritz; M Schwab; E Schaeffeler
ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis.
Clinical pharmacology and therapeutics 2011;89(3):422-8.
2011: Bjoern O Schroeder; Zhihong Wu; Sabine Nuding; Sandra Groscurth; Moritz Marcinowski; Julia Beisner; Johannes Buchner; Martin Schaller; Eduard F Stange; Jan Wehkamp
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1.
Nature 2011;469(7330):419-23.
2011: Anke Tönjes; Henning Wittenburg; Jan Halbritter; Simone Harsch; Frank Lammert; Olga Renner; Eduard F Stange; Michael Stumvoll; Peter Kovacs
Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts.
BMC medical genetics 2011;12():149.
2011: Julia Beisner; Eduard F Stange; Jan Wehkamp
Paneth cell function--implications in pediatric Crohn disease.
Gut microbes 2011;2(1):47-51.
2010: M Escher; Eduard F Stange; K R Herrlinger
Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis--a need for prophylaxis.
Journal of Crohn's & colitis 2010;4(5):606-9.
2010: Jan Wehkamp; Eduard F Stange
Paneth's disease.
Journal of Crohn's & colitis 2010;4(5):523-31.
2010: Julia Beisner; Eduard F Stange; Jan Wehkamp
Innate antimicrobial immunity in inflammatory bowel diseases.
Expert review of clinical immunology 2010;6(5):809-18.
2010: Walter Reinisch; Sieglinde Angelberger; Wolfgang Petritsch; Olga Shonova; Milan Lukas; Simon Bar-Meir; Alexander Teml; Elke Schaeffeler; Matthias Schwab; Karin Dilger; Roland Greinwald; Ralph Mueller; Eduard F Stange; Klaus R Herrlinger
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Gut 2010;59(6):752-9.
2010: Laurent Peyrin-Biroulet; Julia Beisner; Guoxing Wang; Sabine Nuding; Sajit Thottathil Oommen; Denise Kelly; Erika Parmentier-Decrucq; Rodrigue Dessein; Emilie Merour; Philipe Chavatte; Teddy Grandjean; Aude Bressenot; Pierre Desreumaux; Jean-Frédéric Colombel; Béatrice Desvergne; Eduard F Stange; Jan Wehkamp; Mathias Chamaillard
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(19):8772-7.
2010: Klaus R Herrlinger; D N Barthel; K J Schmidt; J Büning; C S Barthel; J Wehkamp; Eduard F Stange; Klaus Fellermann
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
Alimentary pharmacology & therapeutics 2010;31(9):1036-41.
2010: Simon Jäger; Eduard F Stange; Jan Wehkamp
Antimicrobial peptides in gastrointestinal inflammation.
International journal of inflammation 2010;2010():910283.
2010: Philip Rosenstiel; Eduard F Stange
Probiotics and intestinal diseases.
Annals of nutrition & metabolism 2010;57 Suppl():27-8.
2010: Maureen J Koslowski; Julia Beisner; Eduard F Stange; Jan Wehkamp
Innate antimicrobial host defense in small intestinal Crohn's disease.
International journal of medical microbiology : IJMM 2010;300(1):34-40.
2009: I Kübler; M J Koslowski; M Gersemann; Klaus Fellermann; J Beisner; S Becker; K Rothfuss; Klaus R Herrlinger; Eduard F Stange; Jan Wehkamp
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.
Alimentary pharmacology & therapeutics 2009;30(6):621-33.
2009: Charles L Bevins; Eduard F Stange; Jan Wehkamp
Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype.
Gut 2009;58(6):882-3; discussion 883-4.
2009: Olga Renner; Simone Harsch; Elke Schaeffeler; Matthias Schwab; Dietmar M Klass; Wolfgang Kratzer; Eduard F Stange
Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.
Human genetics 2009;125(4):381-91.
2009: Eduard F Stange
For bugs in bile: the times they are a-changin'.
Gastroenterology 2009;136(4):1164-7.
2009: Jan C Preiss; Bernd Bokemeyer; Britta Siegmund; Eduard F Stange; Martin Zeitz; Jörg C Hoffmann
[Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner].
Medizinische Klinik (Munich, Germany : 1983) 2009;104(3):237-43.
2009: Sabine Nuding; Lutz T Zabel; Corinne Enders; Edith Porter; Klaus Fellermann; Jan Wehkamp; Holger A G Mueller; Eduard F Stange
Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3.
Microbes and infection / Institut Pasteur 2009;11(3):384-93.
2009: M Möndel; B O Schroeder; K Zimmermann; H Huber; Sabine Nuding; J Beisner; Klaus Fellermann; Eduard F Stange; Jan Wehkamp
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
Mucosal immunology 2009;2(2):166-72.
2009: Olga Renner; Simone Harsch; Elke Schaeffeler; Stefan Winter; Matthias Schwab; Marcin Krawczyk; Jonas Rosendahl; Henning Wittenburg; Frank Lammert; Eduard F Stange
A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease.
PloS one 2009;4(10):e7321.
2009: Maureen J Koslowski; Irmgard Kübler; Mathias Chamaillard; Elke Schaeffeler; Walter Reinisch; Guoxing Wang; Julia Beisner; Alexander Teml; Laurent Peyrin-Biroulet; Stefan Winter; Klaus R Herrlinger; Paul Rutgeerts; Séverine Vermeire; Rachel Cooney; Klaus Fellermann; Derek Jewell; Charles L Bevins; Matthias Schwab; Eduard F Stange; Jan Wehkamp
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
PloS one 2009;4(2):e4496.
2008: Yoshio Hosaka; Maureen Koslowski; Sabine Nuding; Guoxing Wang; Miriam Schlee; Christian Schäfer; Katunori Saigenji; Eduard F Stange; Jan Wehkamp
Antimicrobial host defense in the upper gastrointestinal tract.
European journal of gastroenterology & hepatology 2008;20(12):1151-8.
2008: Eduard F Stange
In the case of nonresponse, what is the second-level treatment for induction of remission in Crohn's disease?
Inflammatory bowel diseases 2008;14 Suppl 2():S251-2.
2008: Jan Wehkamp; Eduard F Stange
Is there a role for defensins in IBD?
Inflammatory bowel diseases 2008;14 Suppl 2():S85-7.
2008: Olga Renner; Simone Harsch; André Strohmeyer; Silke Schimmel; Eduard F Stange
Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease.
Journal of lipid research 2008;49(9):2045-54.
2008: Eduard F Stange; Simon P L Travis
The European consensus on ulcerative colitis: new horizons?
Gut 2008;57(8):1029-31.
2008: Miriam Schlee; J Harder; B Köten; Eduard F Stange; Jan Wehkamp; Klaus Fellermann
Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2.
Clinical and experimental immunology 2008;151(3):528-35.
2008: Klaus Herrlinger; Eduard F Stange
[Inflammatory bowel diseases--new therapeutic options].
Medizinische Klinik (Munich, Germany : 1983) 2008;103(2):90-101; quiz 102-3.
2008: Klaus Fellermann; Eduard F Stange
How effective is natalizumab induction therapy in patients with Crohn's disease?
Nature clinical practice. Gastroenterology & hepatology 2008;5(2):78-9.
2008: Arthur Holzer; Simone Harsch; Olga Renner; André Strohmeyer; Silke Schimmel; Jan Wehkamp; Peter Fritz; Eduard F Stange
Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation.
Digestion 2008;78(1):52-9.
2007: Guoxing Wang; Eduard F Stange; Jan Wehkamp
Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
Expert review of anti-infective therapy 2007;5(6):1049-57.
2007: Alexander Grupp; Martin Kimmel; Peter Fritz; Bernd Voggenreiter; Hartmut Stöltzing; Ulrich Kuhlmann; Eduard F Stange; Thomas Mettang; Klaus Fellermann; Mark Dominik Alscher
The expression patterns of peritoneal defensins.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2007;27(6):654-62.
2007: Jan Wehkamp; Guoxing Wang; Irmgard Kübler; Sabine Nuding; Alex Gregorieff; Anke Schnabel; Robert J Kays; Klaus Fellermann; Oliver Burk; Matthias Schwab; Hans Clevers; Charles L Bevins; Eduard F Stange
The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):3109-18.
2007: Sabine Nuding; Klaus Fellermann; Jan Wehkamp; Eduard F Stange
Reduced mucosal antimicrobial activity in Crohn's disease of the colon.
Gut 2007;56(9):1240-7.
2007: Jan Wehkamp; Michael Schmid; Eduard F Stange
Defensins and other antimicrobial peptides in inflammatory bowel disease.
Current opinion in gastroenterology 2007;23(4):370-8.
2007: Miriam Schlee; Jan Wehkamp; Artur Altenhoefer; Tobias A Oelschlaeger; Eduard F Stange; Klaus Fellermann
Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.
Infection and immunity 2007;75(5):2399-407.
2007: Michael Schmid; Klaus Fellermann; Peter Fritz; Oliver Wiedow; Eduard F Stange; Jan Wehkamp
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Journal of leukocyte biology 2007;81(4):907-15.
2007: Jan Wehkamp; Jürgen Schauber; Eduard F Stange
Defensins and cathelicidins in gastrointestinal infections.
Current opinion in gastroenterology 2007;23(1):32-8.
2006: Jan Wehkamp; Eduard F Stange
Paneth cells and the innate immune response.
Current opinion in gastroenterology 2006;22(6):644-50.
2006: Klaus Fellermann; Daniel E Stange; Elke Schaeffeler; Hartmut Schmalzl; Jan Wehkamp; Charles L Bevins; Walter Reinisch; Alexander Teml; Matthias Schwab; Peter Lichter; Bernhard Radlwimmer; Eduard F Stange
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.
American journal of human genetics 2006;79(3):439-48.
2006: Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Extraintestinal manifestations and complications in inflammatory bowel diseases.
World journal of gastroenterology : WJG 2006;12(30):4819-31.
2006: Jan Wehkamp; Eduard F Stange
A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
Annals of the New York Academy of Sciences 2006;1072():321-31.
2006: Jürgen Schauber; Daniel Rieger; Frank Weiler; Jan Wehkamp; Matthias Eck; Klaus Fellermann; Wolfgang Scheppach; Richard L Gallo; Eduard F Stange
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
European journal of gastroenterology & hepatology 2006;18(6):615-21.
2006: Sabine Nuding; Klaus Fellermann; Jan Wehkamp; Holger A G Mueller; Eduard F Stange
A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts.
Journal of microbiological methods 2006;65(2):335-45.
2006: Klaus R Herrlinger; Thomas Witthoeft; Andreas Raedler; Bernd Bokemeyer; Thomas Krummenerl; Jorg-Dieter Schulzke; Norbert Boerner; Bruno Kueppers; Joerg Emmrich; Axel Mescheder; Ullrich S Schwertschlag; Mark Shapiro; Eduard F Stange
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
The American journal of gastroenterology 2006;101(4):793-7.
2006: K S Rothfuss; J Christian Bode; Eduard F Stange; Alexandr Parlesak
Urinary excretion of polyethylene glycol 3350 during colonoscopy preparation.
Zeitschrift für Gastroenterologie 2006;44(2):167-72.
2006: Eske Voss; Jan Wehkamp; Kai Wehkamp; Eduard F Stange; Jens Schröder; Jürgen Harder
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
The Journal of biological chemistry 2006;281(4):2005-11.
2006: Ina Bergheim; Simone Harsch; Oliver Mueller; Silke Schimmel; Peter Fritz; Eduard F Stange
Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers.
Journal of lipid research 2006;47(1):42-50.
2005: Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(50):18129-34.
2005: Jan Wehkamp; Klaus Fellermann; Klaus R Herrlinger; Charles L Bevins; Eduard F Stange
Mechanisms of disease: defensins in gastrointestinal diseases.
Nature clinical practice. Gastroenterology & hepatology 2005;2(9):406-15.
2005: Thomas Witthöft; C S Pilz; Klaus Fellermann; M Nitschke; Eduard F Stange; Diether Ludwig
Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2).
Digestive diseases and sciences 2005;50(7):1252-9.
2005: Jan Wehkamp; Eduard F Stange
NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
Trends in molecular medicine 2005;11(7):307-9.
2005: Eduard F Stange
The case against using 5-aminosalicyclates in Crohn's disease: con.
Inflammatory bowel diseases 2005;11(6):613-5.
2005: Jan Wehkamp; Michael Schmid; Klaus Fellermann; Eduard F Stange
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Journal of leukocyte biology 2005;77(4):460-5.
2005: Nils Homann; Ute Klarmann; Klaus Fellermann; Andreas Brüning; Rolf Klingenberg-Noftz; Thomas Witthöft; Eduard F Stange; Diether Ludwig
Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease.
Inflammatory bowel diseases 2005;11(2):126-32.
2005: Jan Wehkamp; Klaus Fellermann; Eduard F Stange
Human defensins in Crohn's disease.
Chemical immunology and allergy 2005;86():42-54.
2004: Susanne Schinke; Klaus Fellermann; Karen Herlyn; Philipp H Reichel; Rilana Fundke; Eduard F Stange; Wolfgang L Gross; Hendrik Schultz
Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
Inflammatory bowel diseases 2004;10(6):763-70.
2004: Jan Wehkamp; Jürgen Harder; Michael Weichenthal; M Schwab; E Schäffeler; Miriam Schlee; Klaus R Herrlinger; A Stallmach; F Noack; P Fritz; Jens Schröder; Charles L Bevins; Klaus Fellermann; Eduard F Stange
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Gut 2004;53(11):1658-64.
2004: Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Schröder; Eduard F Stange
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.
Infection and immunity 2004;72(10):5750-8.
2004: Klaus R Herrlinger; Annette Borutta; Gabriel Meinhardt; Eduard F Stange; Klaus Fellermann
Fatal staphylococcal sepsis in Crohn's disease after infliximab.
Inflammatory bowel diseases 2004;10(5):655-6.
2004: Klaus R Herrlinger; Klaus Fellermann; C Fischer; Wolfgang Kreisel; Peter Deibert; Juergen Schoelmerich; W E Fleig; A Ruhl; M Reinshagen; Roland Greinwald; Eduard F Stange; M Schwab
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
Alimentary pharmacology & therapeutics 2004;19(12):1269-76.
2004: Peter Däubler; Eduard F Stange
[Chronic inflammatory bowel diseases: psychological factors are not implicated].
Pflege Zeitschrift 2004;57(6):386-8.
2004: Klaus R Herrlinger; Rike Dittmann; Gunther Weitz; Jan Wehkamp; Diether Ludwig; Matthias Schwab; Eduard F Stange; Klaus Fellermann
Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Inflammatory bowel diseases 2004;10(3):229-33.
2004: Guoqiang Xu; Oliver Müller; Eduard F Stange; Michael Fuchs
Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.
Biochimica et biophysica acta 2004;1688(3):274-9.
2004: Klaus R Herrlinger; Matthias Schwab; Klaus Fellermann; Eduard F Stange
6-thioguanine-buried alive?
Gastroenterology 2004;126(3):940-1; author reply 941-2.
2003: Tilo Andus; Eduard F Stange; Dieter Höffler; Brigitte Keller-Stanislawski
[Suspected cases of severe side effects after infliximab (Remicade) in Germany].
Medizinische Klinik (Munich, Germany : 1983) 2003;98(8):429-36.
2003: Jan Wehkamp; Jürgen Harder; Michael Weichenthal; Oliver Mueller; Klaus R Herrlinger; Klaus Fellermann; Jens M Schroeder; Eduard F Stange
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
Inflammatory bowel diseases 2003;9(4):215-23.
2003: Klaus R Herrlinger; Peter Deibert; M Schwab; Wolfgang Kreisel; C Fischer; Klaus Fellermann; Eduard F Stange
Remission maintenance by tioguanine in chronic active Crohn's disease.
Alimentary pharmacology & therapeutics 2003;17(12):1459-64.
2003: Klaus Fellermann; Jan Wehkamp; Klaus R Herrlinger; Eduard F Stange
Crohn's disease: a defensin deficiency syndrome?
European journal of gastroenterology & hepatology 2003;15(6):627-34.
2003: Klaus Fellermann; Dagmar Lühmann; Eduard F Stange
Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument.
Inflammatory bowel diseases 2003;9(3):198-201; discussion 202-4.
2003: Jan Wehkamp; Klaus Schmidt; Klaus R Herrlinger; Steffi Baxmann; S Behling; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange; Klaus Fellermann
Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status.
Journal of clinical pathology 2003;56(5):352-7.
2003: Klaus R Herrlinger; Wolfgang Kreisel; M Schwab; Juergen Schoelmerich; W E Fleig; A Ruhl; M Reinshagen; Peter Deibert; Klaus Fellermann; Roland Greinwald; Eduard F Stange
6-thioguanine--efficacy and safety in chronic active Crohn's disease.
Alimentary pharmacology & therapeutics 2003;17(4):503-8.
2003: Klaus Fellermann; Jan Wehkamp; Eduard F Stange
Antimicrobial peptides in the skin.
The New England journal of medicine 2003;348(4):361-3; author reply 361-3.
2003: Matthias Schwab; Elke Schaeffeler; Claudia Marx; Martin F Fromm; Bernd A Kaskas; Joerg Metzler; Eduard F Stange; Hans Herfarth; Juergen Schoelmerich; Michael Gregor; Siegfried Walker; Ingolf Cascorbi; Ivar Roots; Ulrich Brinkmann; Uli Zanger; Michel Eichelbaum
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
Gastroenterology 2003;124(1):26-33.
2002: Klaus Fellermann; Zita Tanko; Klaus R Herrlinger; Thomas Witthoeft; Nils Homann; Andreas Bruening; Diether Ludwig; Eduard F Stange
Response of refractory colitis to intravenous or oral tacrolimus (FK506).
Inflammatory bowel diseases 2002;8(5):317-24.
2002: Boris Brand; Lutz Lerche; Eduard F Stange
Symptomatic or asymptomatic gallstone disease: is the gallbladder motility the clue?
Hepato-gastroenterology 2002;49(47):1208-12.
2002: Jan Wehkamp; Klaus Fellermann; Klaus R Herrlinger; Steffi Baxmann; Klaus Schmidt; Bettina Schwind; Michael Duchrow; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
European journal of gastroenterology & hepatology 2002;14(7):745-52.
2002: Jan Wehkamp; B Schwind; Klaus R Herrlinger; Steffi Baxmann; Klaus Schmidt; Michael Duchrow; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange; Klaus Fellermann
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.
Digestive diseases and sciences 2002;47(6):1349-55.
2002: Jörg Metzler; Eduard F Stange
[Biological therapies for treatment of chronic inflammatory bowel diseases. Status update].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(5):290-7.
2002: Eduard F Stange
[Evidence-based guideline for the diagnosis and treatment of ulcerative colitis].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2002;96(4):239-42.
2002: Eduard F Stange
[Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
Zeitschrift für Gastroenterologie 2002;40 Suppl 1():S90-S1.
2002: Klaus R Herrlinger; M K Noftz; K Dalhoff; Diether Ludwig; Eduard F Stange; Klaus Fellermann
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
The American journal of gastroenterology 2002;97(2):377-81.
2002: William J Sandborn; Brian G Feagan; Stephen B Hanauer; Herbert Lochs; Robert Löfberg; Robert Modigliani; Daniel H Present; Paul Rutgeerts; Jurgen Schölmerich; Eduard F Stange; Lloyd R Sutherland
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Gastroenterology 2002;122(2):512-30.
2002: Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.
The Biochemical journal 2002;361(Pt 3):673-9.
2001: Michael Fuchs; A Hafer; C Münch; Frank Kannenberg; S Teichmann; Jürgen Scheibner; Eduard F Stange; Udo Seedorf
Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism.
The Journal of biological chemistry 2001;276(51):48058-65.
2001: Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Indirect evidence that intestinal bile salt absorption in rats and hamsters is under positive feedback control.
Zeitschrift für Gastroenterologie 2001;39(11):929-36.
2001: Klaus Fellermann; Eduard F Stange
Defensins -- innate immunity at the epithelial frontier.
European journal of gastroenterology & hepatology 2001;13(7):771-6.
2001: Michael Fuchs; B Ivandic; O Müller; C Schalla; Jürgen Scheibner; P Bartsch; Eduard F Stange
Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
Hepatology (Baltimore, Md.) 2001;33(6):1451-9.
2001: Klaus Fellermann; Klaus R Herrlinger; Thomas Witthoeft; Nils Homann; Diether Ludwig; Eduard F Stange
Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.
Transplantation proceedings 2001;33(3):2247-8.
2001: Klaus R Herrlinger; M K Noftz; Klaus Fellermann; K Schmidt; Jürgen Steinhoff; Eduard F Stange
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.
Alimentary pharmacology & therapeutics 2001;15(3):363-9.
2001: Klaus Fellermann; B Rudolph; Thomas Witthöft; Klaus R Herrlinger; M Tronnier; Diether Ludwig; Eduard F Stange
[Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(2):105-8.
2001: T David-Walek; C Niederstadt; PM Rob; Lutz Fricke; K Latta; Jürgen Steinhoff; Eduard F Stange
Primary hyperoxaluria type 1 causing end-stage renal disease in a 45-year-old patient.
Nephron 2001;87(1):80-4.
2000: Klaus Fellermann; Eduard F Stange
Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology?
Hepato-gastroenterology 2000;47(35):1422-4.
2000: M Fuchs; FM Reimann; Christian Gaebel; Diether Ludwig; Eduard F Stange
Treatment of infected pancreatic pseudocysts by endoscopic ultrasonography-guided cystogastrostomy.
Endoscopy 2000;32(8):654-7.
2000: Diether Ludwig; S Schädel; Andreas Brüning; B Schiefer; Eduard F Stange
48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
Digestive diseases and sciences 2000;45(5):1019-27.
2000: Klaus R Herrlinger; Eduard F Stange
[Azathioprine in chronic inflammatory bowel diseases. Evidence base].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(4):201-6.
2000: FM Reimann; U Samson; I Derad; M Fuchs; B Schiefer; Eduard F Stange
Synergistic sedation with low-dose midazolam and propofol for colonoscopies.
Endoscopy 2000;32(3):239-44.
2000: Klaus Fellermann; M Steffen; J Stein; Andreas Raedler; J Hämling; Diether Ludwig; K Loeschke; Eduard F Stange
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2000;14(2):171-6.
2000: Hendrik Schimmelpenning; Jens K Habermann; S Krüger; Uwe J Roblick; Eduard F Stange; D Ludwig; Peter Kujath; Rainer Broll; Gert Auer; Hans-Peter Bruch
[Ulcerative colitis-associated colorectal carcinoma. DNA ploidy as indicator of impending malignant transformation?].
Zentralblatt für Chirurgie 2000;125(11):880-7.
2000: D Ludwig; Eduard F Stange
Treatment of ulcerative colitis.
Hepato-gastroenterology 2000;47(31):83-9.
1999: Diether Ludwig; Eduard F Stange
Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.
Zeitschrift für Gastroenterologie 1999;37(11):1085-91.
1999: Diether Ludwig; S Wiener; Andreas Brüning; K Schwarting; Günter Jantschek; Eduard F Stange
Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study.
The American journal of gastroenterology 1999;94(10):2942-50.
1999: Diether Ludwig; S Wiener; Andreas Brüning; K Schwarting; Günter Jantschek; Klaus Fellermann; M Stahl; Eduard F Stange
Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.
Gut 1999;45(4):546-52.
1999: Diether Ludwig; S Terai; Andreas Brüning; Eduard F Stange
Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study.
Alimentary pharmacology & therapeutics 1999;13(8):1119-29.
1999: Diether Ludwig; M Stahl; E T Ibrahim; Björn E. Wenzel; D Drabicki; A Wecke; Klaus Fellermann; Eduard F Stange
Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases.
Digestive diseases and sciences 1999;44(7):1440-7.
1999: Jürgen Scheibner; Michael Fuchs; E Hörmann; Eduard F Stange
Complex feedback regulation of bile acid synthesis in the hamster: the role of newly synthesized cholesterol.
Hepatology (Baltimore, Md.) 1999;30(1):230-7.
1999: G Kallien; K Lange; Eduard F Stange; Jürgen Scheibner
The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans.
Hepatology (Baltimore, Md.) 1999;30(1):14-20.
1999: W Kern; Eduard F Stange; H L Fehm; H H Klein
[Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases].
Zeitschrift für Gastroenterologie 1999;Suppl 1():36-42.
1999: Herbert Lochs; Guido Adler; C Beglinger; R Duchmann; J Emmrich; K Ewe; Alfred Gangl; C Gasché; E Hahn; P Hoffmann; Bernd A Kaskas; Helmut Malchow; C Pohl; Andreas Raedler; E Renner; Jurgen Schölmerich; Stefan Schreiber; Eduard F Stange; H Tilg; Harald Vogelsang; N Weigert; M Zeitz
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
Zeitschrift für Gastroenterologie 1999;37(6):509-12.
1999: A Woywodt; Diether Ludwig; P Neustock; A Kruse; K Schwarting; Günter Jantschek; Holger Kirchner; Eduard F Stange
Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.
European journal of gastroenterology & hepatology 1999;11(3):267-76.
1999: Eduard F Stange
[Consequences of galenic differences and outcome of clinical trials with budesonide and 5-aminosalicylic acids for therapy of Crohn disease].
Medizinische Klinik (Munich, Germany : 1983) 1999;94 Suppl 1():39-41.
1999: B Schiefer; Eduard F Stange
[Motility diagnosis in chronic constipation].
Zentralblatt für Chirurgie 1999;124(9):775-83.
1998: Eduard F Stange
["Therapy of Crohn disease" guideline. German Society of Digestive and Metabolic Diseases].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1998;92(10):697-700.
1998: Klaus Fellermann; Diether Ludwig; M Stahl; T David-Walek; Eduard F Stange
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
The American journal of gastroenterology 1998;93(10):1860-6.
1998: Diether Ludwig; M Stahl; T David-Walek; Andreas Brüning; A Siemens; Martin Zwaan; G Schmücker; Eduard F Stange
Ischemic colitis, pulmonary embolism, and right atrial thrombosis in a patient with inherited resistance to activated protein C.
Digestive diseases and sciences 1998;43(6):1362-7.
1998: M Stahl; Diether Ludwig; Klaus Fellermann; Eduard F Stange
Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis.
Digestive diseases and sciences 1998;43(5):1079-87.
1998: Diether Ludwig; K Schwarting; C M Korbel; Andreas Brüning; B Schiefer; Eduard F Stange
The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis.
Journal of hepatology 1998;28(4):631-8.
1998: B Brand; J Groth; Lutz Lerche; Eduard F Stange
Intensified ESWL of gallstones: dissociation of pulverisation, pain relief and stone-clearance.
Hepato-gastroenterology 1998;45(19):70-6.
1997: Jürgen Scheibner; K Lange; K Empen; Eduard F Stange
The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans.
Zeitschrift für Ernährungswissenschaft 1997;36(4):368-71.
1997: Klaus Fellermann; M Stahl; K Dahlhoff; MJ Amthor; Diether Ludwig; Eduard F Stange
Crohn's disease and sarcoidosis: systemic granulomatosis?
European journal of gastroenterology & hepatology 1997;9(11):1121-4.
1997: Eduard F Stange; Stefan Schreiber; Andreas Raedler; A Stallmach; Jurgen Schölmerich; K Loeschke; M Starlinger; W Fischbach; W F Caspary
[Therapy of Crohn diseases--results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases].
Zeitschrift für Gastroenterologie 1997;35(7):541-54.
1997: FM Reimann; M Schreiber; Lutz Lerche; Andreas Brüning; Eduard F Stange
[Gastrointestinal problems in elderly patients].
Zeitschrift für Gerontologie und Geriatrie 1997;30(3):208-19.
1997: Werner Kern; B Schiefer; J Schwarzenburg; Eduard F Stange; Jan Born; Horst L Fehm
Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans.
Neuroendocrinology 1997;65(4):291-8.
1997: A Klinger; FM Reimann; M H Klinger; Eduard F Stange
Clathrin-mediated endocytosis of high density lipoprotein3 in human intestinal Caco-2 cells. A post-embedding immunocytochemical study.
Biochimica et biophysica acta 1997;1345(1):65-70.
1997: K Empen; K Lange; Eduard F Stange; Jürgen Scheibner
Newly synthesized cholesterol in human bile and plasma: quantitation by mass isotopomer distribution analysis.
The American journal of physiology 1997;272(2 Pt 1):G367-73.
1996: FM Reimann; F Winkelmann; Klaus Fellermann; Eduard F Stange
Reduced cholesterol esterification in CaCo-2 cells by indirect action of pravastatin.
Atherosclerosis 1996;125(1):63-70.
1996: G Tauber; K Empen; Jürgen Scheibner; M Fuchs; Eduard F Stange
Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans.
European journal of gastroenterology & hepatology 1996;8(1):23-31.
1996: Hans Weidenbach; Jürgen Scheibner; Eduard F Stange; Guido Adler; Karl-Heinz Beckh
Reduction of bile secretion by prostaglandins in the rat in vivo.
Life sciences 1996;58(18):1531-8.
1995: Eduard F Stange; R Modigliani; A S Peña; A J Wood; G Feutren; P R Smith
European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group.
Gastroenterology 1995;109(3):774-82.
1995: Armin Schnabel; K Dalhoff; Eduard F Stange; U Mrowietz; Wolfgang L Gross
[Methotrexate therapy of inflammatory diseases. Reliable effects and recent developments in rheumatology, pneumology, gastroenterology and dermatology].
Medizinische Klinik (Munich, Germany : 1983) 1995;90(6):364-71.
1995: MH Schoenberg; D Birk; K Beckh; Eduard F Stange; E Frohneiser; Guido Adler; Hans G Beger
[Endoscopic and surgical therapy of hemorrhagic duodenal and stomach ulcer].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1995;66(4):326-33.
1995: Jürgen Scheibner; M Fuchs; M Schiemann; Eduard F Stange
Deoxycholate and cholate modulate the source of cholesterol substrate for bile acid synthesis in the rat.
Hepatology (Baltimore, Md.) 1995;21(2):529-38.
1995: G Herold; R Jungwirth; Gerhard Rogler; Irmlind Geerling; Eduard F Stange
Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2).
Digestion 1995;56(1):57-66.
1994: G Herold; U Hesse; F Wisst; C Fahr; M Fahr; Gerhard Rogler; Irmlind Geerling; Eduard F Stange
HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins A-I and A-II.
Lipids 1994;29(11):735-45.
1994: A Woywodt; P Neustock; A Kruse; K Schwarting; Diether Ludwig; Eduard F Stange; Holger Kirchner
Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.
European cytokine network 1994;5(4):387-95.
1994: G Herold; Gerhard Rogler; D Rogler; Eduard F Stange
Morphology of CaCo-2 cells varies in different cell batches.
In vitro cellular & developmental biology. Animal 1994;30A(5):289-91.
1994: Jürgen Scheibner; M Fuchs; E Hörmann; G Tauber; Eduard F Stange
Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol.
Journal of lipid research 1994;35(4):690-7.
1993: Jürgen Scheibner; M Fuchs; M Schiemann; G Tauber; E Hörmann; Eduard F Stange
Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat.
Hepatology (Baltimore, Md.) 1993;17(6):1095-102.
1993: G Herold; Eduard F Stange
Sclerotherapy of duodenal varices using a fibrin tissue sealant.
Endoscopy 1993;25(5):371-2.
1993: G Herold; F Besemer; D Rogler; Gerhard Rogler; Eduard F Stange
Polyamine deficiency impairs proliferation and differentiation of cultured enterocytes (CaCo-2).
Zeitschrift für Gastroenterologie 1993;31(2):120-8.
1992: Klaus Fellermann; FM Reimann; G Herold; Eduard F Stange
Mevinolin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, suppresses enterocyte esterification of exogenous but not endogenous cholesterol.
Biochimica et biophysica acta 1992;1165(1):78-83.
1992: G Preclik; Eduard F Stange; Herwig H Ditschuneit
Limited utilization of exogenous arachidonic acid by the prostaglandin cyclooxygenase in gastric mucosa: the role of protein binding, glutathione peroxidase, and hydrogen peroxides.
Prostaglandins 1992;44(3):177-97.
1992: M Fuchs; Jürgen Scheibner; E Hörmann; G Tauber; Eduard F Stange
Enterohepatic circulation in hamsters with an extracorporeal bile duct.
Journal of lipid research 1992;33(9):1383-91.
1992: Gerhard Rogler; G Herold; C Fahr; M Fahr; D Rogler; FM Reimann; Eduard F Stange
High-density lipoprotein 3 retroendocytosis: a new lipoprotein pathway in the enterocyte (Caco-2).
Gastroenterology 1992;103(2):469-80.
1992: G Preclik; G Abedin; Eduard F Stange; K Baczako; Herwig H Ditschuneit
[Endogenous prostaglandin synthesis and gastritis: lack of correlation with endoscopic findings, Helicobacter colonization and leukocytic infiltration of the mucosa].
Zeitschrift für Gastroenterologie 1992;30(2):130-3.
1992: FM Reimann; G Herold; I Grosshans; Gerhard Rogler; Klaus Fellermann; Eduard F Stange
Regulation of cholesterol metabolism and low-density lipoprotein binding in human intestinal Caco-2 cells.
Digestion 1992;51(1):10-7.
1992: G Preclik; Eduard F Stange; Herwig H Ditschuneit
Activation of PGE2-secretion from gastric mucosa by a type I phospholipase C is mediated by a direct release of arachidonic acid.
Clinical physiology and biochemistry 1992;9(2):78-86.
1991: Eduard F Stange; M Osenbrügge; M Rustan; FM Reimann; A Schneider; Herwig H Ditschuneit; H Ditschuneit
Inhibition of HMG-CoA reductase in mononuclear cells during gemfibrozil treatment.
Atherosclerosis 1991;91(3):257-65.
1991: Gerhard Rogler; G Herold; Eduard F Stange
HDL3-retroendocytosis in cultured small intestinal crypt cells: a novel mechanism of cholesterol efflux.
Biochimica et biophysica acta 1991;1095(1):30-8.
1991: FM Reimann; G Herold; A Schneider; Eduard F Stange
Compartmentalization of cholesterol metabolism and cellular growth in cultured intestinal crypt cells.
Biochimica et biophysica acta 1991;1085(3):315-21.
1991: H Horn; G Preclik; Eduard F Stange; Herwig H Ditschuneit
Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes.
Scandinavian journal of gastroenterology 1991;26(8):867-79.
1991: G Preclik; Eduard F Stange; D Arnold; Herwig H Ditschuneit
In vitro effects of arachidonic acid on the prostaglandin synthesizing system in gastric mucosa.
Prostaglandins 1991;41(4):359-73.
1991: Eduard F Stange; Gerhard Rogler; FM Reimann; G Herold
[Cholesterol absorption and metabolism in the small intestine].
Zeitschrift für Gastroenterologie. Verhandlungsband 1991;26():100-1.
1991: Eduard F Stange; M Frühholz; M Osenbrügge; FM Reimann; Herwig H Ditschuneit
Bezafibrate fails to directly modulate HMG-CoA reductase or LDL catabolism in human mononuclear cells.
European journal of clinical pharmacology 1991;40 Suppl 1():S37-40.
1990: G Herold; E Seifried; P Hildebrand; Eduard F Stange; Herwig H Ditschuneit
[Local lysis of peritoneovenous shunt thrombosis with rt-PA].
Zeitschrift für Gastroenterologie 1990;28(11):626-9.
1990: Eduard F Stange; U Schmid; W E Fleig; Herwig H Ditschuneit
[Exclusion diet in Crohn disease: a controlled, randomized study].
Zeitschrift für Gastroenterologie 1990;28(10):561-4.
1990: R Nuber; H Maucher; Eduard F Stange
Size exclusion chromatography for extraction of serum bile acids.
Journal of lipid research 1990;31(8):1517-22.
1990: G Herold; Gerhard Rogler; FM Reimann; Eduard F Stange
[Regulation of intestinal cholesterol metabolism].
Klinische Wochenschrift 1990;68 Suppl 22():1-6.
1989: G Preclik; Eduard F Stange; K Gerber; G Fetzer; H Horn; A Schneider; Herwig H Ditschuneit
Effect of antacid treatment on endogenous prostaglandin synthesis in human antral and duodenal mucosa.
Digestive diseases and sciences 1989;34(12):1860-4.
1989: Eduard F Stange; J Dylla; W E Fleig
Laser treatment of upper gastrointestinal tract carcinoma: determinants of survival.
Endoscopy 1989;21(6):254-7.
1989: Eduard F Stange; W E Fleig; E Rehklau; Herwig H Ditschuneit
Cyclosporin A treatment in inflammatory bowel disease.
Digestive diseases and sciences 1989;34(9):1387-92.
1989: Eduard F Stange; Jürgen Scheibner; H Ditschuneit
Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo.
The Journal of clinical investigation 1989;84(1):173-80.
1989: G Preclik; Eduard F Stange; K Gerber; G Fetzer; H Horn; Herwig H Ditschuneit
Alimentary tract and pancreas. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment.
Gut 1989;30(2):148-51.
1988: Eduard F Stange; Jürgen Scheibner; C Lutz; H Ditschuneit
Feedback regulation of bile acid synthesis in the rat by dietary vs. intravenous cholate or taurocholate.
Hepatology (Baltimore, Md.) 1988;8(4):879-86.
1988: Eduard F Stange; G Preclik; A Schneider; FM Reimann
The role of enterocyte cholesterol metabolism in intestinal cell growth and differentiation.
Scandinavian journal of gastroenterology. Supplement 1988;151():79-85.
1988: FM Reimann; G Herold; Eduard F Stange
Compartmentalisation of cholesterol metabolism in cultured intestinal cells.
Agents and actions. Supplements 1988;26():67-81.
1987: W E Fleig; Eduard F Stange; K Winkler
[Is there a hepatogenic ulcer? Prospective study of the incidence of peptic ulcer in portal hypertension].
Zeitschrift für Gastroenterologie 1987;25 Suppl 3():47-51.
1987: Eduard F Stange; G Preclik; K Gerber; G Fetzer; H Horn; A Schneider; Herwig H Ditschuneit
[Prostaglandin synthesis in stomach and duodenal mucosa of the human: effect of aspirin with and without antacid].
Zeitschrift für Gastroenterologie 1987;25 Suppl 3():162-5.
1987: G Preclik; Eduard F Stange; Herwig H Ditschuneit
[Regulation of endogenous prostaglandin synthesis in the upper gastrointestinal tract].
Zeitschrift für Gastroenterologie 1987;25 Suppl 3():102-6.
1987: G Preclik; Eduard F Stange; D Arnold; O Kraft; A Schneider; Herwig H Ditschuneit
Prostaglandin synthesis along the gastrointestinal tract of the rabbit: differences in total synthesis and profile.
Prostaglandins 1987;33(3):459-77.